Our Products
Our products support the health of patients in the areas of maternal and women's health, anemia management and cancer supportive care. More
Research & Development
We recognize the immense value of clinical research and are committed to investing in it to expand the body of knowledge in our therapeutic areas and advance potential future health innovations for patients. More
AMAG Corporate Principles
Our company values provide an important framework for who we are and how we operate. AMAG is also committed to a set of corporate principles that guide how we pursue our business goals and deliver on our promise to patients and their families. More
News
AMAG PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF VYLEESI™ (BREMELANOTIDE...
AMAG PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF VYLEESI™ (BREMELANOTIDE INJECTION) FOR ACQUIRED, GENERALIZED HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) IN PREMENOPAUSAL WOMEN
The First FDA-Approved As-Needed Treatment for Premenopausal Women Experiencing Distress or Interpersonal Difficulty Due to Low Sexual Desire MoreWorking at AMAG
"I get to wear a lot of different hats in an industry that provides very fast-paced and interesting work along with the opportunity to solve the puzzle of treatments for difficult diseases."
David Knauss
Senior Manager, Regulatory Affairs & Medical Writing
